Morphological and Hemodynamic Effectiveness of Stenting for Pulmonary Artery Stenosis - Subanalysis of JPIC Stent

Takanari Fujii1, Hideshi Tomita, Kazuto Fujimoto

  • 1Cardiovascular Center, Showa University Northern Yokohama Hospital.

Insights

Percutaneous stenting for branch pulmonary artery stenosis is effective in congenital heart disease. Reference vessel diameter and percent diameter stenosis before stenting predict successful outcomes.

Area of Science:

  • Interventional Cardiology
  • Congenital Heart Disease
  • Pediatric Cardiology

Background:

  • Percutaneous stenting is a key treatment for branch pulmonary artery stenosis in congenital heart disease.
  • Morphological changes in vessel diameter after stenting may not always reflect hemodynamic improvements.

Purpose of the Study:

  • To evaluate the relationship between morphological and hemodynamic effectiveness of percutaneous stenting in branch pulmonary artery stenosis.
  • To identify predictors of successful stenting outcomes.

Main Methods:

  • Subanalysis of data from the Japanese Society of Pediatric Interventional Cardiology (JPIC) stent survey.
  • Evaluation of 206 stenting lesions, defining morphological effectiveness as a 50% increase in minimum lumen diameter (MLD).
  • Defining hemodynamic effectiveness as a >50% reduction in pressure gradient or a >20% increase in perfusion ratio.

Main Results:

  • Morphological effectiveness was achieved in 84% of patients.
  • Pre-stenting reference vessel diameter (RVD) and percent diameter stenosis (%DS) were significant predictors of effectiveness.
  • Effective stenting was associated with a %DS cutoff of 51% and RVD of 14.7 mm.

Conclusions:

  • RVD and %DS are crucial factors for acute morphological effectiveness in pulmonary artery stenting.
  • A strong correlation exists between morphological and hemodynamic effectiveness, indicated by improved lung perfusion and reduced pressure gradients.
Abstract

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.1K
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
387
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
422